Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 530

1.

Recommendations to improve identification of hereditary and familial colorectal cancer in Europe.

Vasen HF, Möslein G, Alonso A, Aretz S, Bernstein I, Bertario L, Blanco I, Bulow S, Burn J, Capella G, Colas C, Engel C, Frayling I, Rahner N, Hes FJ, Hodgson S, Mecklin JP, Møller P, Myrhøj T, Nagengast FM, Parc Y, Ponz de Leon M, Renkonen-Sinisalo L, Sampson JR, Stormorken A, Tejpar S, Thomas HJ, Wijnen J, Lubinski J, Järvinen H, Claes E, Heinimann K, Karagiannis JA, Lindblom A, Dove-Edwin I, Müller H.

Fam Cancer. 2010 Jun;9(2):109-15. doi: 10.1007/s10689-009-9291-3. Epub 2009 Sep 18.

PMID:
19763885
2.

Challenges in the diagnosis and management of Lynch Syndrome in an Indigenous family living in a remote West Australian community.

Schofield L, Goldblatt J, Iacopetta B.

Rural Remote Health. 2011;11(4):1836. Epub 2011 Dec 22.

3.

Prospective results of surveillance colonoscopy in dominant familial colorectal cancer with and without Lynch syndrome.

Dove-Edwin I, de Jong AE, Adams J, Mesher D, Lipton L, Sasieni P, Vasen HF, Thomas HJ.

Gastroenterology. 2006 Jun;130(7):1995-2000.

PMID:
16762622
6.

Scoping the family history: assessment of Lynch syndrome (hereditary nonpolyposis colorectal cancer) in primary care settings--a primer for nurse practitioners.

Maradiegue A, Jasperson K, Edwards QT, Lowstuter K, Weitzel J.

J Am Acad Nurse Pract. 2008 Feb;20(2):76-84. doi: 10.1111/j.1745-7599.2007.00282.x. Review.

PMID:
18271762
7.

Detection of mismatch repair gene germline mutation carrier among Chinese population with colorectal cancer.

Jin HY, Liu X, Li VK, Ding Y, Yang B, Geng J, Lai R, Ding S, Ni M, Zhao R.

BMC Cancer. 2008 Feb 7;8:44. doi: 10.1186/1471-2407-8-44.

8.

One to 2-year surveillance intervals reduce risk of colorectal cancer in families with Lynch syndrome.

Vasen HF, Abdirahman M, Brohet R, Langers AM, Kleibeuker JH, van Kouwen M, Koornstra JJ, Boot H, Cats A, Dekker E, Sanduleanu S, Poley JW, Hardwick JC, de Vos Tot Nederveen Cappel WH, van der Meulen-de Jong AE, Tan TG, Jacobs MA, Mohamed FL, de Boer SY, van de Meeberg PC, Verhulst ML, Salemans JM, van Bentem N, Westerveld BD, Vecht J, Nagengast FM.

Gastroenterology. 2010 Jun;138(7):2300-6. doi: 10.1053/j.gastro.2010.02.053. Epub 2010 Mar 2.

PMID:
20206180
9.
10.

Early-age-at-onset colorectal cancer and microsatellite instability as markers of hereditary nonpolyposis colorectal cancer.

Pucciarelli S, Agostini M, Viel A, Bertorelle R, Russo V, Toppan P, Lise M.

Dis Colon Rectum. 2003 Mar;46(3):305-12.

PMID:
12626904
11.

Very low prevalence of germline MSH6 mutations in hereditary non-polyposis colorectal cancer suspected patients with colorectal cancer without microsatellite instability.

Kets CM, van Krieken JH, Hebeda KM, Wezenberg SJ, Goossens M, Brunner HG, Ligtenberg MJ, Hoogerbrugge N.

Br J Cancer. 2006 Dec 18;95(12):1678-82. Epub 2006 Nov 21.

12.

Risk of gynecologic cancers in Danish hereditary non-polyposis colorectal cancer families.

Boilesen AE, Bisgaard ML, Bernstein I.

Acta Obstet Gynecol Scand. 2008;87(11):1129-35. doi: 10.1080/00016340802443806.

PMID:
18972272
13.

[Management of hereditary non-polyposis syndrome (Lynch syndrome)].

Kariv R, Goldberg Y, Soler I, Rosner G, Half E, Moshkowitz M, Vilkin A, Levi Z, Niv Y.

Harefuah. 2011 Apr;150(4):392-6, 416. Hebrew.

PMID:
22164924
14.

Screening for germline mutations of MLH1, MSH2, MSH6 and PMS2 genes in Slovenian colorectal cancer patients: implications for a population specific detection strategy of Lynch syndrome.

Berginc G, Bracko M, Ravnik-Glavac M, Glavac D.

Fam Cancer. 2009;8(4):421-9. doi: 10.1007/s10689-009-9258-4. Epub 2009 Jun 13.

PMID:
19526325
16.

Optimizing the detection of hereditary non-polyposis colorectal cancer: an update.

De Bruin JH, Ligtenberg MJ, Nagengast FM, Adang EM, Van Krieken JH, Hoogerbrugge N.

Scand J Gastroenterol Suppl. 2006;(243):146-52. Review.

PMID:
16782634
17.

Clinical features and mismatch repair genes analyses of Chinese suspected hereditary non-polyposis colorectal cancer: a cost-effective screening strategy proposal.

Yan HL, Hao LQ, Jin HY, Xing QH, Xue G, Mei Q, He J, He L, Sun SH.

Cancer Sci. 2008 Apr;99(4):770-80. doi: 10.1111/j.1349-7006.2008.00737.x. Epub 2008 Feb 27.

18.

Genetic testing in gastroenterology: Lynch syndrome.

Grover S, Syngal S.

Best Pract Res Clin Gastroenterol. 2009;23(2):185-96. doi: 10.1016/j.bpg.2009.02.006. Review.

PMID:
19414145
19.

Immunoassay for wild-type protein in lymphocytes predicts germline mutations in patients at risk for hereditary colorectal cancer.

Fields JZ, Gao Z, Gao Z, Lewis M, Maimonis P, Harvey J, Lynch HT, Boman BM.

J Lab Clin Med. 2004 Jan;143(1):59-66.

PMID:
14749686
20.

Can we identify the high-risk patients to be screened? A genetic approach.

Gammon A, Kohlmann W, Burt R.

Digestion. 2007;76(1):7-19. Epub 2007 Oct 19. Review.

PMID:
17947814
Items per page

Supplemental Content

Write to the Help Desk